Cytokinetics, Incorporated
PublicCytokinetics, Incorporated is now publicly traded
The data on this page reflects Cytokinetics, Incorporated's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Angel
Apr 11, 2022
Total Funding Raised
$3M
Company Overview
Cytokinetics, Incorporated is a biopharmaceutical company that discovers, develops, and commercializes muscle activators and inhibitors to treat cardiovascular and neuromuscular diseases.
Sector
Biotech
AI Layer
Non-AI
Keywords
biopharmaceuticalbiotechmuscle activatorcardiac muscle therapyamyotrophic lateral sclerosisALShypertrophic cardiomyopathysmall-molecule drugdrug discoveryclinical trialscardiovascular diseaseneuromuscular diseasepharma stockbiotech pipeline
Cytokinetics, Incorporated Comparables
Compare Cytokinetics, Incorporated with similar companies based on industry and business-model similarity.
Cytokinetics, Incorporated Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Apr 11, 2022 |
Cytokinetics, Incorporated Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersSouth San Francisco, California
Employee Range25
Year Founded1997
Last FundingApr 11, 2022